UTHR
United Therapeutics Corp
Price:  
231.92 
USD
Volume:  
769,660.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

UTHR EV/EBITDA

77.5%
Upside

As of 2024-03-02, the EV/EBITDA ratio of United Therapeutics Corp (UTHR) is 9.09. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. UTHR's latest enterprise value is 10,590.22 mil USD. UTHR's TTM EBITDA according to its financial statements is 1,165.40 mil USD. Dividing these 2 quantities gives us the above UTHR EV/EBITDA ratio.

Range Selected
Trailing P/E multiples 13.2x - 16.9x 14.2x
Forward P/E multiples 17.3x - 20.9x 18.9x
Fair Price 334.42 - 514.16 411.72
Upside 44.2% - 121.7% 77.5%
231.92 USD
Stock Price
411.72 USD
Fair Price

UTHR EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-03-01 9.09
2024-02-29 8.83
2024-02-28 8.90
2024-02-27 8.88
2024-02-26 8.75
2024-02-23 8.89
2024-02-22 8.51
2024-02-21 8.57
2024-02-20 8.37
2024-02-16 8.39
2024-02-15 8.39
2024-02-14 8.38
2024-02-13 8.35
2024-02-12 8.46
2024-02-09 8.30
2024-02-08 8.27
2024-02-07 8.23
2024-02-06 8.40
2024-02-05 8.31
2024-02-02 8.34
2024-02-01 8.44
2024-01-31 8.40
2024-01-30 8.41
2024-01-29 8.48
2024-01-26 8.53
2024-01-25 8.58
2024-01-24 8.56
2024-01-23 8.52
2024-01-22 8.45
2024-01-19 8.52
2024-01-18 8.57
2024-01-17 8.70
2024-01-16 8.55
2024-01-12 8.57
2024-01-11 8.62
2024-01-10 8.67
2024-01-09 8.78
2024-01-08 9.05
2024-01-05 8.99
2024-01-04 9.01
2024-01-03 8.94
2024-01-02 8.90
2023-12-29 8.60
2023-12-28 8.58
2023-12-27 8.40
2023-12-26 8.46
2023-12-22 8.56
2023-12-21 8.54
2023-12-20 8.83
2023-12-19 9.42